Trials / Active Not Recruiting
Active Not RecruitingNCT06867900
Unexplained Recurrent Pregnancy Loss: New Therapeutic Perspectives
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 22 (actual)
- Sponsor
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Evaluation of gut permeability and endometrial inflammasome NLRP3 in women with unexplaid recurrent pregnancy loss before-after administration of Bifidobacteriumlongum ES1.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Bifidobacterium Longum ES1 | Oral administration of Bifidobacterium Longum ES1 for three months. |
Timeline
- Start date
- 2021-01-01
- Primary completion
- 2023-07-05
- Completion
- 2025-07-06
- First posted
- 2025-03-10
- Last updated
- 2025-03-10
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT06867900. Inclusion in this directory is not an endorsement.